« Characterization of a human H5N1 influenza A virus isolated in 2003. | Main | Protecting human and ecological health under viral threats in Asia. »

August 05, 2005

Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.

Vaccine. 2005 Jul 9;
Epstein SL, Kong WP, Misplon JA, Lo CY, Tumpey TM, Xu L, Nabel GJ

Influenza epidemic and pandemic strains cannot be predicted with certainty. Current vaccines elicit antibodies effective against specific strains, but new strategies are urgently needed for protection against unexpected strains. DNA vaccines encoding conserved antigens protect animals against diverse subtypes, but their potency needs improvement. We tested DNA prime-recombinant adenoviral boost immunization to nucleoprotein (NP). Strong antibody and T cell responses were induced. Protection against challenge was T cell-dependent and substantially more potent than DNA vaccination alone. Importantly, vaccination protected against lethal challenge with highly pathogenic H5N1 virus. Thus, gene-based vaccination with NP may contribute to protective immunity against diverse influenza viruses through its ability to stimulate cellular immunity.

Posted by dymaxion at August 5, 2005 02:28 PM


Post a comment

Remember Me?